Education
About Us
Working with TipRanks
Follow Us
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.84M | $ 5.23M |
| Gross Profit | $ 0.00 | $ -10.05K | $ -6.68K | $ 1.82M | $ 5.23M |
| Operating Income | $ 0.00 | - | $ -31.84M | $ -12.81M | $ -7.79M |
| EBITDA | $ 0.00 | - | $ -31.60M | $ -12.75M | $ -7.33M |
| Net Income | $ -5.58M | - | $ -31.37M | $ -12.70M | $ -7.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.43M | $ 5.90M | $ 12.11M | $ 29.21M | $ 11.12M |
| Total Assets | $ 3.02M | $ 6.59M | $ 14.65M | $ 40.83M | $ 24.93M |
| Total Debt | $ 221.87K | $ 289.64K | $ 0.00 | $ 0.00 | $ 477.03K |
| Net Debt | $ -2.21M | $ -5.61M | $ -12.11M | $ -29.21M | $ -10.64M |
| Total Liabilities | $ 1.51M | $ 1.30M | $ 4.27M | $ 2.11M | $ 2.77M |
| Stockholders' Equity | $ 1.51M | $ 5.29M | $ 10.38M | $ 38.72M | $ 22.16M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.53M | $ -12.85M | $ -19.10M | $ -10.20M | $ -10.31M |
| Operating Cash Flow | $ -4.53M | $ -12.85M | $ -17.60M | $ -10.20M | $ -10.31M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -1.50M | $ 0.00 | $ -2.60K |
| Financing Cash Flow | $ 1.06M | $ 6.64M | $ 1.99M | $ 28.30M | $ 17.69M |